Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2020
Pharma News, 2020
Merck's Keytruda wins U.S. FDA approval for bladder cancer
(Reuters) - The U.
Boehringer Ingelheim's bet on Chinese CDMO market pays off with BeiGene's mAb approval
Germany-based Boehringer Ingelheim opened this €70 million biologics manufacturing facility in Shanghai to produce cell-based drugs targeted primarily at China.
Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture
Avacta Group plc (AIM.
Bristol-Myers Squibb Completes Divestment of Manufacturing Facility in Anagni, Italy
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE.
Towa adds EU production in deal for Spanish generics maker
Japanese generics maker Towa Pharmaceutical has scored its first European manufacturing site with the purchase of the generics unit of Spain’s Esteve.
CDMO WuXi STA opens manufacturing facility to produce oligonucleotides
CDMO WuXi STA is building out its manufacturing site in Changzhou, China in stages.
With cancer kickoff, Amgen bets on BeiGene's fast-growing Chinese sales force
Compared with multinational rivals such as Novartis, Roche and AstraZeneca, Amgen didn’t have a strong oncology presence in China.
'Totally bummed' Nobel Prize winner admits a 'painful' mistake
TORONTO -- A Nobel Prize winner has admitted she “did not do her job well” after a scientific paper published last year was retracted.
In China, 44 people became ill with an unknown form of pneumonia
In China, 44 people fell ill with an unknown form of pneumonia, condition 11 was assessed as severe, and 121 more were under surveillance.
Pfizer, BMS, Gilead, AbbVie and others hike prices on hundreds of meds to ring in 2020
It may be a new year, but an old tradition is playing out in the pharma world—the price-hiking tradition, that is.
FDA approves UVA-developed artificial pancreas
The U.
More January U.S. price hikes take 2020 tally to over 330 drugs with higher cost
NEW YORK (Reuters) - AbbVie Inc on Thursday raised the cost of rheumatoid arthritis treatment Humira, the world’s top-selling medicine, joining other drugmakers that have now hiked U.
71
72
73
74
75
76
